BioLife Solutions (NASDAQ: BLFS) reported Q4 EPS of ($0.37), $0.20 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $37.3 million versus the consensus estimate of $35.81 million.

GUIDANCE:

BioLife Solutions sees FY2022 revenue of $159.5-171 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.